3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Status
Completed
19
Withdrawn
2
Unknown
2
Terminated
1
Recruiting
1
Sponsor Class
OTHER
21
INDUSTRY
2
OTHER_GOV
1
Study Type
Interventional
2
Sponsor
Conditions
Neoplasms
183
Breast Neoplasms
174
Carcinoma, Non-Small-Cell Lung
173
Colorectal Neoplasms
105
Stomach Neoplasms
81
Pancreatic Neoplasms
79
Lung Neoplasms
79
Prostatic Neoplasms
77
Melanoma
68
Neoplasm Metastasis
67
Recurrence
66
Leukemia, Myeloid, Acute
66
Multiple Myeloma
64
Ovarian Neoplasms
62
Carcinoma, Hepatocellular
62
Lymphoma
61
Advanced Solid Tumor
61
Advanced Solid Tumors
56
Solid Tumor
50
Uterine Cervical Neoplasms
48
Lymphoma, Non-Hodgkin
48
Glioblastoma
44
Lymphoma, B-Cell
40
Leukemia
39
Colonic Neoplasms
34
Precursor Cell Lymphoblastic Leukemia-Lymphoma
33
Head and Neck Neoplasms
33
Esophageal Neoplasms
32
Urinary Bladder Neoplasms
30
Sarcoma
30
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Unknown
×
INDUSTRY
×
Myofibroma
×
Clear all
NCT03550703
2018-07-06
V3-myoma
Immunitor LLC
Phase 2
Unknown
30 enrolled
NCT03219385
2018-03-21
DIANA
Mirabilis Medica, Inc.
Phase NA
Unknown
180 enrolled